nsclc - Robuta Search

https://www.harmonictrial.com/ Harmonic™ Clinical Trial for Never Smokers With NSCLC Harmonic™ Clinical Trial: A Study of LP-300 With Carboplatin and Pemetrexed in Never Smokers With Advanced Lung Adenocarcinoma clinical trial never smokers nsclc https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2022.920047/full Frontiers | Is ICI-based therapy better than chemotherapy for metastatic NSCLC patients who develop... Purpose: To evaluate the outcomes of immune checkpoint inhibitors (ICIs) based treatments versus classical chemotherapy for metastatic non-small cell lung ca... https://blackdoctor.com/living-with-nsclc-6-treatment-options-to-consider/ Living with NSCLC? 6 Treatment Options to Consider - BlackDoctor - Where Culture Meets Care Mar 6, 2026 - A diagnosis of non-small cell lung cancer (NSCLC) can feel overwhelming, but there are many effective treatment options available today. Whether you are newly https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2024.1382197/full Frontiers | Three-year follow-up study reveals improved survival rate in NSCLC patients underwent... Background: No studies in China have assessed the guideline-concordance level of the first-course of non-small cell lung cancer (NSCLC) diagnosis and treatme... https://intl.youyao.cc/products/ceritinib-spexib Spexib Ceritinib (ALK) 150mg150 NSCLC India ceritinib alk nsclc india https://legalitalia.org/article/neoadjuvant-chemoimmunotherapy-for-nsclc-surgical-outcomes-and-challenges Neoadjuvant Chemoimmunotherapy for NSCLC: Surgical Outcomes and Challenges (2026) May 19, 2026 - The world of thoracic surgery is undergoing a profound transformation, and a recent meta-analysis by Bertoglio and colleagues is shedding light on the impact... surgical outcomes nsclc challenges https://pubmed.ncbi.nlm.nih.gov/26308162/ A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): Old successes and... The discovery of Epidermal Growth Factor Receptor (EGFR) mutations in Non Small Cell Lung Cancer (NSCLC) launched the era of personalized medicine in advanced... https://www.cancernetwork.com/view/setting-expectations-for-long-term-therapy-in-egfr-mutated-nsclc Setting Expectations for Long-Term Therapy in EGFR-Mutated NSCLC | CancerNetwork May 15, 2026 - In this segment, Dr. Alexander Spira and Dr. Natalie Vokes discuss how to effectively counsel patients starting adjuvant EGFR tyrosine kinase inhibitor therapy... setting expectations long term https://flagshipbio.com/poster-comprehensive-image-analysis-of-immunostained-nsclc-tissues/ Comprehensive Image Analysis Of Immunostained NSCLC Tissues Provides Necessary Context For Immune... image analysis https://astrazeneca.trialsummaries.com/Study/StudyDetails?uniqueStudyId=D933IC00001&tenant=MT_MED_9011 TrialSummaries.com - A study of novel anti-cancer agents in patients with previously untreated NSCLC A study of novel anti-cancer agents in patients with previously untreated NSCLC https://ecancer.org/en/video/10307-recent-advances-in-the-treatment-of-patients-with-exon-20-insertion-positive-nsclc Recent advances in the treatment of patients with exon 20 insertion-positive NSCLC - ecancer Dr Alfredo Addeo (University Hospital of Geneva, Geneva, Switzerland), Prof Nicolas Girard (Institut Curie, Paris, France) and Prof Natasha Leighl (Princess Mar https://cms.biodesix.com/tag/egfrerlotinibnccn-guidelinesnsclcpress-releasesveristratblood-based-cancer-testblood-based-protein-profiling-testcancer-diagnosticschemotherapyliquid-biopsylung-canceroncology/ EGFR,Erlotinib,NCCN Guidelines,NSCLC,Press Releases,Veristrat,blood-based cancer test,blood-based... nccn guidelines press releases https://www.agcongress.it/project/immuno-oncologia-nel-nsclc-non-small-cell-lung-cancer-avanzato-esperienze-di-pratica-clinica-a-confronto-2/ Immuno oncologia nel NSCLC (Non Small Cell Lung Cancer) avanzato: esperienze di pratica clinica a... https://lifestyle.all80sz1063.com/story/182218/cellworks-study-supports-liquid-biopsy-for-predicting-chemo-immunotherapy-benefit-in-advanced-nsclc/ Cellworks Study Supports Liquid Biopsy for Predicting Chemo-Immunotherapy Benefit in Advanced NSCLC... https://www.texasoncology.com/clinical-trials/24149-Ph-3-Study-of-Nivo-Relatlimab-w-Chemo-vs-Pembro-w-Chemo-FL-NSQ-NSCLC-PD-L1 Ph 3 Study of Nivo + Relatlimab w/ Chemo vs Pembro w/Chemo FL NSQ NSCLC PD-L1 | Clinical Trial |... Learn more about Phase III Clinical Trial for Lung Cancer at Texas Oncology. https://intl.youyao.cc/products/alectinib-alecensa-chn Alecensa Alectinib (ALK/RET) 150mg224caps NSCLC China Mainland Alecensa (generic name: Alectinib, target: ALK, RET) is produced by Roche Pharmaceuticals (China Mainland), a subsidiary of Roche Group in China. It is a... alectinib alk ret nsclc china https://www.worldpharmaceuticals.net/news/enhertu-treat-nsclc/ US FDA grants breakthrough therapy designation for Enhertu to treat NSCLC - World Pharmaceutical... May 19, 2020 - Enhertu is indicated for the treatment of metastatic in patients whose tumours have a HER2 mutation and with disease progression after platinum-based therapy https://nichenest.xyz/breakthrough-bispecific-immunotherapy-pioneering-multi-target-nsclc-solutions/ Breakthrough Bispecific Immunotherapy: Pioneering Multi-Target NSCLC Solutions - Niche Nest May 28, 2025 - The field of lung cancer therapeutics is undergoing a remarkable transformation as bispecific antibodies establish themselves as cornerstone treatments in... breakthrough bispecific immunotherapy pioneering multi https://lcfamerica.org/tag/nsclc-en/ NSCLC Archives | LCFA nsclc archives lcfa https://cms.biodesix.com/tag/in-the-newsnsclcnon-small-cell-lung-cancerblood-based-cancer-testcancer-diagnosticsliquid-biopsylung-canceroncologypersonalized-medicine/ In the News,NSCLC,Non-Small Cell Lung Cancer,blood-based cancer test,cancer diagnostics,liquid... small cell lung cancer in the news https://www.grgonline.com/post/targeted-therapies-in-nsclc-current-landscape-and-emerging-agents Targeted Therapies in NSCLC: Advances and Treatment Options Mar 25, 2025 - Explore the latest in targeted therapies for NSCLC, from established treatments to emerging agents, offering precision and hope for improved patient outcomes. targeted therapies nsclc advances treatment options https://www.news-medical.net/news/20171207/New-first-line-combination-therapy-shows-promising-results-in-patients-with-advanced-NSCLC.aspx New first line combination therapy shows promising results in patients with advanced NSCLC Jun 18, 2019 - A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS),... https://lungsummit.org/project_tag/metastatic-nsclc/page/2/ Metastatic NSCLC | Lung Summit metastatic nsclc lung summit https://www.sifact.it/comparative-efficacy-of-chemo-immunotherapy-combination-regimens-in-the-frontline-setting-for-nsclc-based-on-reconstructed-patient-data/ Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC... https://pubmed.ncbi.nlm.nih.gov/10960939/ Advances in treatment of inoperable NSCLC: gemcitabine doublets--a promising alternative Gemcitabine (Gemzar) was originally approved for use in combination with cisplatin (Platinol) for the treatment of advanced non-small-cell lung cancer (NSCLC).... in treatment advances inoperable https://findtrial.co/trial/ChiCTR2000037509 Individualized treatment of driver gene-negative advanced NSCLC patients with malignant pleural... Clinical trial for Lung Cancer individualized treatment https://www.mylungcancerteam.com/resources/wearable-device-approved-to-treat-advanced-nsclc Wearable Device Approved To Treat Advanced NSCLC | MyLungCancerTeam The U.S. Food and Drug Administration (FDA) has approved Optune Lua, a portable device that delivers tumor treating fields (TTFields) to help treat metasta wearable device advanced nsclc approved treat https://www.ilcn.org/crown-results-demonstrate-longest-progression-free-survival-in-advanced-nsclc-seen-to-date/ CROWN Results Demonstrate Longest Progression-Free Survival in Advanced NSCLC Seen to Date -... Jun 25, 2024 - When presenting the data, Dr. Benjamin Solomon said first-line lorlatinib offers unprecedented improvement in outcomes for patients with advanced ALK+... https://keytruda.cz/videos/kazuistika-pacienta-s-metastazujicim-skvamoznim-nsclc-leceneho-v-kombinaci-s-pd%e2%80%91l1-1/ Kazuistika pacienta s metastazujícím skvamózním NSCLC léčeného v kombinaci s PD‑L1 1 % - Keytruda... May 4, 2026 - MUDr. Alžběta Bejčková https://virginiacancerspecialists.com/disease/non-small-lung-cancer/non-small-cell-lung-cancer-diagnosis/ NSCLC Diagnosis at Virginia Cancer Specialists Aug 5, 2023 - We perform multiple tests like laboratory tests, MRI, radionuclide bone scan, endoscopic ultrasound to accurately diagnose lung cancer and its stage. nsclc diagnosis virginia cancer specialists https://deceraclinical.com/education/activities/oncology/early-stage-nsclc-treatment/29300-55914/info Adjuvant and Neoadjuvant Therapy in Early-Stage NSCLC | Decera Clinical Education This downloadable slideset includes expert perspectives on the use of contemporary adjuvant and neoadjuvant therapy for patients with early-stage... early stage adjuvant therapy https://cancertreatments.co.nz/glossary/metastatic-nsclc/ Metastatic NSCLC | Roche metastatic nsclc roche https://deceraclinical.com/education/activities/oncology/egfr+-nsclc:-multidisciplinary-overview/100002164/info iEGFR/i+ NSCLC: Multidisciplinary Overview - Podcast Episode - HER3 Lung | Decera Clinical... Podcast of a multidisciplinary discussion of the latest management strategies for EGFR-mutated NSCLC, including for EGFR TKI resistant disease, from Clinical... overview podcast nsclc multidisciplinary https://lcfamerica.org/research-news/deep-learning-in-nsclc-care/ Deep Learning in NSCLC Care | LCFA Jan 3, 2024 - Deep learning in NSCLC care can be sed to predict 1, 2, and 5-year mortality from pretreatment CTs of patients with stage I-IV lung cancer. deep learning nsclc care lcfa https://ar.iiarjournals.org/content/25/6C/4759 Inhibition of EGFR Tyrosine-kinase in NSCLC Treatment: the Hungarian Experience with Gefitinib in... The ZD1839 (Iressa, gefitinib) treatment in phase I trials for patients with advanced non-small cell lung cancer (NSCLC) was associated with disease... https://www.journalonko.de/thorakale-tumoren/nsclc/nsclc-wer-profitiert-von-der-neoadjuvanten-immuntherapie NSCLC: Wer profitiert von der (neo)adjuvanten Immuntherapie? Apr 29, 2026 - Adjuvant, neoadjuvant, perioperativ – was ist die beste immuntherapeutische Strategie für Patient:innen mit NSCLC? Hier erfahren Sie mehr! nsclc wer von der neo https://biotechhunter.com/trials/NCT06396065 NCT06396065 - Phase III Study of AK112 for NSCLC Patients | Biotech Hunter | Biotech Hunter View clinical trial NCT06396065 details phase iii study https://database.inahta.org/article/22704 [Amivantamab (NSCLC) - Benefit nsclc benefit https://nsclc-biomarkers-ime.springermedicine.com/ Biomarker-driven management of NSCLC May 12, 2026 - The discovery of oncogenic driver alterations and the development of targeted therapies have revolutionized cancer treatment. biomarker driven management nsclc https://www.agcongress.it/project/immuno-oncologia-nel-nsclc-non-small-cell-lung-cancer-avanzato-esperienze-di-pratica-clinica-a-confronto-treviso-18-giugno-2019/ Immuno oncologia nel NSCLC (Non Small Cell Lung Cancer) avanzato: esperienze di pratica clinica a... https://scholars.houstonmethodist.org/en/publications/relationship-between-tumor-size-and-survival-in-non-small-cell-lu/ Relationship between tumor size and survival in Non-Small-Cell Lung Cancer (NSCLC): An analysis of... https://iris.unibs.it/handle/11379/500637 From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a... https://www.clinrol.com/study/509 A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1) | Clinrol Phase 1a/1b study of NVL-330 to evaluate safety, tolerability, and antitumor activity in advanced/metastatic HER2-altered NSCLC. https://www.accc-cancer.org/view/defining-high-quality-nsclc-care-at-us-cancer-centers ACCC | [Abstract #229] Defining High-Quality NSCLC Care at US Cancer Centers Presented at the 2020 ASCO Quality Care Symposium, October 9 to October 10, 2020. high quality https://eprints.whiterose.ac.uk/id/eprint/128942/ Radical radiotherapy for non-small cell lung cancer (NSCLC): real world outcomes for two... small cell lung cancer https://visualping.io/pages/m7824-combination-with-chemotherapy-in-stage-iv-nsclc-clinical-trial-alerts-4959069 M7824 Combination with Chemotherapy in Stage IV NSCLC Clinical Trial: Get alerts for the latest... See the latest updates to M7824 Combination with Chemotherapy in Stage IV NSCLC Clinical Trial. Subscribe for free to get alerts when changes are detected to... https://christie.openrepository.com/entities/publication/e8a13292-b847-41af-9cab-2a284103bec6 CBCT is not valid for response evaluation after chemoradiotherapy for locally advanced NSCLC is not https://tristargroup.us/product/rnascope-pre-qualified-lung-cancer-tma-sclc-nsclc-adc-nsclc-scc-histopath-data-sub-set-with-egfr-mutation-status-ta3168/ RNAscope pre-qualified Lung cancer TMA (SCLC, NSCLC (ADC), NSCLC (SCC), histopath data, sub-set... https://www.thno.org/v12p7051.htm ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated... ERK inactivation enhances stemness of NSCLC cells via promoting Slug-mediated epithelial-to-mesenchymal transition erk enhances https://iris.uniupo.it/handle/11579/159413 Antibiotic Exposure and Immune Checkpoint Inhibitors in Patients With NSCLC: The Backbone Matters immune checkpoint inhibitors https://www.bioworld.com/articles/697515-in-392m-deal-c4-and-betta-partner-in-china-on-preclinical-nsclc-drug?v=preview In $392M deal, C4 and Betta partner in China on preclinical NSCLC drug | BioWorld In a deal potentially worth $392 million, C4 Therapeutics Inc. signed with Betta Pharmaceuticals Co. Ltd. to develop and market an orally bioavailable BiDAC... https://pharmadispatch.com/news/immutep-reaches-enrolment-target-for-insight-003-trial-in-first- Immutep reaches enrolment target for INSIGHT-003 trial in first line NSCLC - BioPharmaDispatch Australian clinical-stage biotechnology company Immutep (ASX:IMM) has announced that the investigator-initiated INSIGHT-003 trial has reached its enrolment... https://www.pharmafocuseurope.com/news/fda-accepts-nda-for-zipalertinib-to-treat-advanced FDA accepts NDA for zipalertinib to treat advanced NSCLC with EGFR exon 20 insertion mutations The U.S. Food and Drug Administration has accepted a New Drug Application (NDA) for zipalertinib for the treatment of patients with locally advanced or... https://deceraclinical.com/education/activities/oncology/metex14+-nsclc:-faq-part-1/1000011242/content iMET/iex14+ NSCLC: FAQ Part 1 - Podcast Episode - NSCLC METex14 | Decera Clinical Education Podcast with international lung cancer expert answers to clinician questions from a live CCO Webinar on METex14+ NSCLC, topics including MET exon 14 testing,... https://cms.biodesix.com/publication/pre-treatment-sera-from-nsclc-patients-with-different-outcomes-on-egfr-tki-therapy-differentially-affect-sensitivity-of-lung-cancer-cell-lines-to-egfr-tkis/ Pre-treatment sera from NSCLC patients with different outcomes on EGFR-TKI therapy differentially... https://keytruda.cz/videos/kazusitika-pacienta-s-metastazujicim-neskvamoznim-nsclc-s-pd-l1-50/ Kazusitika pacienta s metastazujícím neskvamózním NSCLC s PD-L1 50 % - Keytruda Czech pacienta https://www.stocktitan.net/news/OCEA/ocean-biomedical-announces-breakthrough-findings-in-egfr-mutant-lung-xdtsir185nwu.html OCEA: Lung Cancer Breakthrough - Novel Therapy Shows Promise in Drug-Resistant NSCLC | OCEA Stock... Feb 10, 2025 - Revolutionary immunotherapy restores treatment sensitivity in resistant lung cancer, demonstrates powerful tumor reduction when combined with TKI therapies.... https://www.ilcn.org/the-rationale-for-local-consolidation-therapy-in-oncogene-driven-nsclc/ The Rationale for Local Consolidation Therapy in Oncogene-Driven NSCLC - ILCN.org (ILCN/WCLC) Dec 27, 2021 - The availability of effective TKIs for patients with metastatic NSCLC with targetable oncogenes such as EGFR, ALK, ROS1, and BRAF has transformed the treatment... https://www.bmsstudyconnect.com/cz/en/clinical-trials/NCT05609578.html Combination Therapies With Adagrasib in Patients With Advanced NSCLC With KRAS G12C Mutation | BMS... Study CA239-0010 is an open-label, Phase 2 clinical trial evaluating the clinical efficacy of adagrasib in combination with pembrolizumab and chemotherapy in... combination therapies https://www.iqwig.de/en/presse/press-releases/press-releases-detailpage_49472.html Adjuvant treatment of NSCLC: Certain patients benefit from osimertinib. Hint of considerable added benefit if adjuvant platinum-based chemotherapy has already been administered after complete tumour resection or is not suitable. adjuvant treatment nsclc certain patients https://www.agcongress.it/project/immunoterapia-nel-nsclc-avanzato-dagli-studi-clinici-alla-real-world-evidence-milano-mi-4-aprile-2025/ Immunoterapia nel NSCLC avanzato: dagli studi clinici alla real-world evidence - Milano (MI) 4... https://www.bmsstudyconnect.com/pl/pl/clinical-trials/NCT03195491.html A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy... The purpose of this study is to investigate the safety of patients in Asia with Non-Small Cell Lung Cancer (NSCLC)who are treated with Nivolumab monotherapy as... small cell lung cancer https://laafon.com/emrelis-for-nsclc/ EMRELIS For NSCLC (Telisotuzumab Vedotin): Targeted Hope or Cautious Bet? - Laafon Galaxy... May 26, 2025 - Explore EMRELIS for NSCLC (telisotuzumab vedotin-tllv), a targeted antibody-drug conjugate for c-Met overexpressed non-squamous NSCLC. Learn its mechanism,... https://www.iaslc.org/iaslc-news/press-release/studies-give-new-insights-immunotherapy-elderly-patients-advanced-nsclc Studies give new insights on immunotherapy in elderly patients with advanced NSCLC | IASLC Geneva, Switzerland - Two studies to be reported at ELCC 2019 (1,2) provide new insights on the efficacy and safety of immunotherapy in elderly patients with a... https://digimedupdates.com/merck-launches-phase-3-kandlelit-007-trial-of-calderasib-plus-keytruda-qlex-in-nsclc/ Merck Launches Phase 3 KANDLELIT-007 Trial of Calderasib Plus KEYTRUDA QLEX in NSCLC | Digimed... https://www.integraconnect.com/resources/blog/ispor-new-data-highlights-need-for-increased-egfr-testing-in-nsclc-spots-alarming-gaps-for-asian-american-patients/ ISPOR: New data highlights need for increased EGFR testing in NSCLC; spots alarming gaps for Asian... Learn about the latest data from ISPOR highlighting the need for increased EGFR testing in NSCLC and identifying gaps in care for Asian American patients. Read... https://www.cirm.ca.gov/about-cirm/publications/rare-population-cd24itgb4notchhi-cells-drives-tumor-propagation-nsclc-and-requires-notch3-self-renewal/ A rare population of CD24(+)ITGB4(+)Notch(hi) cells drives tumor propagation in NSCLC and requires... https://visualping.io/pages/nsclc-carboplatin-pemetrexed-bevacizumab-atezolizumab-clinical-trial-alerts-4958838 NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial: Get alerts for the latest... See the latest updates to NSCLC Carboplatin+Pemetrexed+Bevacizumab+/-Atezolizumab Clinical Trial. Subscribe for free to get alerts when changes are detected to... clinical trial https://mlabs.umich.edu/tests/obsolete-alk-rearrangement-nsclc-fish OBSOLETE ALK Rearrangement for NSCLC by FISH | MLabs obsolete alk nsclc fish mlabs https://research-repository.uwa.edu.au/en/publications/sunvozertinib-for-nsclc-patients-with-egfr-exon-20-insertion-muta/ Sunvozertinib for NSCLC patients with EGFR exon 20 insertion mutations: Preliminary analysis of... https://academictorrents.com/details/95b58ebfc1952780cfe2102dd7290889feefad66/tech&filelist=1 Non-Small Cell Lung Cancer CT Scan Dataset (NSCLC-Radiomics-Genomics) - Technical - Academic... This collection contains images from 89 non-small cell lung cancer (NSCLC) patients that were treated with surgery. For these patients pretreatment CT scans,... small cell lung cancer https://triaadv.com/article/neoadjuvant-chemoimmunotherapy-for-nsclc-surgical-outcomes-and-challenges Neoadjuvant Chemoimmunotherapy for NSCLC: Surgical Outcomes and Challenges (2026) May 14, 2026 - The world of thoracic surgery is undergoing a profound transformation, and a recent meta-analysis by Bertoglio and colleagues is shedding light on the impact... surgical outcomes nsclc challenges https://nsclc.lungevity.org/nsclc/news-and-events?field_tags_target_id=84 News and Events | Navigating NSCLC news and events navigating nsclc https://flcube.com/?p=11607 Beijing Aosaikang's Combo Therapy for NSCLC Accepted for Clinical Trial by NMPA - Insight, China's... Nov 6, 2024 - Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755), a Chinese pharmaceutical company, has announced that the China National Medical Products... https://www.over-view.it/ NSCLC - Over-view nsclc view https://www.medicalhalo.com/en/oncology/2398.html Platinib has durable activity in Chinese patients with RET fusion + NSCLC_Medicalhalo Data from the global Phase 1/2 ARROW study (BLU-667-1101; NCT03037385) presented at the 2021 World Lung Cancer Conference showed that the use of pralsetinib... in chinese https://alumni.rbht.nhs.uk/events/128047 Local Consolidation After Systemic Therapy for NSCLC - Thoracic Surgery Virtual Grand Round | Royal... Professor Shankar Siva, Peter MacCallum Cancer Centre, AU Professor Siva, Radiation Oncologist at the Peter MacCallum Cancer Centre in Victoria, current Cancer... https://blackdoctor.com/nsclc-what-you-need-to-know/?amp NSCLC: What You Need to Know - BlackDoctor - Where Culture Meets Care Mar 6, 2026 - If you or a loved one has been diagnosed with non-small cell lung cancer (NSCLC), you likely have many questions and concerns. This guide provides essential what you need to know nsclc https://www.amgen-oncology.at/onkologie/lungenkarzinom/sotorasib-beim-wclc-2024 NSCLC: Sotorasib beim WCLC 2024 nsclc wclc https://egfrcancer.org/2024/03/19/ablative-radiotherapy-controls-resistant-non-small-cell-lung-cancer-in-clinical-trial/ Ablative Radiotherapy Controls Resistant NSCLC in Clinical Trial | EGFR Lung Cancer Resisters Mar 19, 2024 - An MSK team has shown that stereotactic body radiotherapy (SBRT) can keep oligoprogressive lung cancer under control more than 4 times longer than when... https://ascopost.com/issues/april-25-2026/ai-driven-multiagent-system-for-guiding-first-line-immunotherapy-for-nsclc/ AI-Driven Multiagent System for Guiding First-Line Immunotherapy for NSCLC - The ASCO Post An artificial intelligence (AI) multiagent system demonstrated correct and complete reasoning in determining the use of immunotherapy for patients with... https://aceatherapeutics.com/patients/lung-cancer-nsclc/ EGFR-mutant Non-Small Cell Lung Cancer (NSCLC) - ACEA Aug 23, 2023 - Lung cancer is the most prevalent form of cancer in the world and is notoriously difficult to treat. Approximately 230,000 people are diagnosed with lung...... small cell lung cancer egfr mutant non nsclc https://visualping.io/pages/pembrolizumab-ferumoxytol-mri-in-nsclc-brain-metastases-clinical-trial-alerts-4958818 Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial: Get alerts for the latest... See the latest updates to Pembrolizumab+Ferumoxytol MRI in NSCLC Brain Metastases Clinical Trial. Subscribe for free to get alerts when changes are detected to... https://ctv.veeva.com/study/auy922-in-patient-with-stage-iv-nsclc AUY922 in Patient With Stage IV NSCLC This is an open-label, single-arm, multicenter phase II trial in patients with stage IV EGFR T790M, EGFR exon 20 and other uncommon, HER2, or BRAF-mutated;... in patient with stage iv nsclc https://ascopost.com/issues/december-15-2014/appetite-enhancing-agent-helps-patients-treated-for-nsclc-gain-weight-and-lean-body-mass-and-feel-better/ Appetite-Enhancing Agent Helps Patients Treated for NSCLC Gain Weight and Lean Body Mass and Feel... https://www.ilcn.org/can-2409-plus-valacyclovir-extends-survival-in-ici-refractory-nsclc/ CAN-2409 Plus Valacyclovir Extends Survival in ICI-Refractory NSCLC - ILCN.org (ILCN/WCLC) Nov 4, 2025 - The final OS and safety data support the development of a phase III randomized clinical trial, Dr. Charu Aggarwal said. https://harmonytaxilimo.com/article/neoadjuvant-chemoimmunotherapy-for-nsclc-surgical-outcomes-and-challenges Neoadjuvant Chemoimmunotherapy for NSCLC: Surgical Outcomes and Challenges (2026) May 20, 2026 - The world of thoracic surgery is undergoing a profound transformation, and a recent meta-analysis by Bertoglio and colleagues is shedding light on the impact... surgical outcomes nsclc challenges https://genekor.com/lv/publications/tumor-molecular-profiling-of-nsclc-patients-using-next-generation-sequencing/ Tumor molecular profiling of NSCLC patients using next generation sequencing. - Genekor Tsoulos N, Papadopoulou E, Metaxa-Mariatou V, Tsaousis G, Efstathiadou C, Tounta G, Scapeti A, Bourkoula E, Zarogoulidis P, Pentheroudakis G, Kakolyris S,... next generation sequencing tumor molecular profiling nsclc